Interleukin 27 (IL-27) is a pleiotropic cytokine that was initially shown to promote Th1 differentiation while antagonizing Th17 development during Ag priming phase of the immune response. However, an emerging paradigm is that IL-27 activates c-Maf leading to the up-regulation of Aryl hydrocarbon receptor, culminating in sustained expression of IL-10 that promote development of Tr1 cell. Our previous work showed that (i) IL-27 is constitutively expressed in retinal ganglion and photoreceptor cell layers and that the up-regulation of IL-27 by retina cells inhibits proliferation of Th17-cells during EAU. We suggested a mechanism by which Th1 cells mitigate uveitis by antagonizing Th17 expansion through IFN-g-mediated induction of IL-27 in target tissue. During this review period, our investigation focused on: (a) identifying retinal cells that produce IL-27 and retinal cells that express the IL-27 receptor and respond to IL-27;(b) examining potential physiological benefits of constitutive secretion of IL-27 by retinal cells. Our studies revealed the following: (i) That microglia cells in the neuroretina constitutively secrete IL-27 and up-regulated their expression of IL-27 during uveitis. (ii) Photoreceptors constitutively express IL-27 receptor and responded to IL-27 signaling by producing anti-inflammatory molecules through STAT1-dependent mechanisms. (iii) Suppression of EAU was mediated through IL-27-induced production of IL-10, SOCS1 and SOCS3 by retinal cells and the SOCS proteins protected retinal cells from cytokine-mediated apoptosis. Taken together, these studies suggest that IL-27 may be beneficial in the treatment of CNS inflammatory diseases, such as, uveitis and multiple sclerosis.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Investigator-Initiated Intramural Research Projects (ZIA)
Project #
1ZIAEY000372-13
Application #
8737623
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
13
Fiscal Year
2013
Total Cost
$236,392
Indirect Cost
Name
U.S. National Eye Institute
Department
Type
DUNS #
City
State
Country
Zip Code
Wan, Chi-Keung; He, Chang; Sun, Lin et al. (2016) Cutting Edge: IL-1 Receptor Signaling is Critical for the Development of Autoimmune Uveitis. J Immunol 196:543-6
Wang, Xiaoqian; Wei, Yinxiang; Xiao, He et al. (2016) A novel IL-23p19/Ebi3 (IL-39) cytokine mediates inflammation in Lupus-like mice. Eur J Immunol 46:1343-50
Wang, Xiaoqian; Wei, Yinxiang; Xiao, He et al. (2016) Pre-existing CD19-independent GL7(-) Breg cells are expanded during inflammation and in mice with lupus-like disease. Mol Immunol 71:54-63
Egwuagu, C E; Sun, L; Kim, S-H et al. (2015) Ocular Inflammatory Diseases: Molecular Pathogenesis and Immunotherapy. Curr Mol Med 15:517-28
Kim, Sung-Hye; Burton, Jenna; Yu, Cheng-Rong et al. (2015) Dual Function of the IRF8 Transcription Factor in Autoimmune Uveitis: Loss of IRF8 in T Cells Exacerbates Uveitis, Whereas Irf8 Deletion in the Retina Confers Protection. J Immunol 195:1480-8
Egwuagu, Charles E; Yu, Cheng-Rong (2015) Interleukin 35-Producing B Cells (i35-Breg): A New Mediator of Regulatory B-Cell Functions in CNS Autoimmune Diseases. Crit Rev Immunol 35:49-57
Sun, Lin; He, Chang; Nair, Lekha et al. (2015) Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease. Cytokine 75:249-55
He, Chang; Yu, Cheng-Rong; Sun, Lin et al. (2015) Topical administration of a suppressor of cytokine signaling-1 (SOCS1) mimetic peptide inhibits ocular inflammation and mitigates ocular pathology during mouse uveitis. J Autoimmun 62:31-8
Yu, Cheng-Rong; Hayashi, Kozaburo; Lee, Yun Sang et al. (2015) Suppressor of cytokine signaling 1 (SOCS1) mitigates anterior uveitis and confers protection against ocular HSV-1 infection. Inflammation 38:555-65
Egwuagu, Charles E; Yu, Cheng-Rong; Sun, Lin et al. (2015) Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases. Cytokine Growth Factor Rev 26:587-93

Showing the most recent 10 out of 20 publications